Engineering Herpes Simplex Virus Vectors for CNS Applications

This publication has 49 references indexed in Scilit:

• Enhancement of the Herpes Simplex Virus Thymidine Kinase/Ganciclovir Bystander Effect and Its Antitumor Efficacy In Vivo by Pharmacologic Manipulation of Gap Junctions
  Human Gene Therapy, 1998
• Genetic Transfer of the Wobbler Gene to a C57BL/6J × NZB Hybrid Stock: Natural History of the Motor Neuron Disease and Response to CNTF and BDNF Cotreatment
  Experimental Neurology, 1997
• Retroviral Transfer of Herpes Simplex Thymidine Kinase Gene into Glioma Cells Causes Targeting of Gancyclovir Cytotoxic Effect
  Neurologia medico-chirurgica, 1994
• In VitroEvidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene Therapy
  Human Gene Therapy, 1993
• Thymidine kinase-mediated killing of rat brain tumors
  Journal of Neurosurgery, 1993
• Gene Therapy of Cancer
  Cancer Investigation, 1993
• Characterization of the promoter region of the murine fibroblast growth factor receptor 1 gene
  Biochemical and Biophysical Research Communications, 1992
• Mapping of Low Abundance Latency-associated RNA in the Trigeminal Ganglia of Mice Latently Infected with Herpes Simplex Virus Type 1
  Journal of General Virology, 1990
• GAL4-VP16 is an unusually potent transcriptional activator
  Nature, 1988
• Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1987